Drug Executive Collapses During Oval Office Press Conference
A press conference in the Oval Office was suddenly interrupted when a drug executive fainted while President Donald Trump announced a deal to reduce prices for obesity medications.
Details of the Incident
The event involved President Trump and pharmaceutical companies Eli Lilly and Novo Nordisk discussing an agreement to expand coverage and lower prices for their obesity treatments, Zepbound and Wegovy. During remarks by Eli Lilly's CEO, David Ricks, he noticed the executive and asked,
“Are you okay? Gordon, are you okay?”
The man who collapsed was Gordon Findlay, global brand director for Novo Nordisk. Dr. Mehmet Oz immediately stepped in as Findlay fell to his knees and lost consciousness. Health and Human Services Secretary was also present during the incident.
Aftermath and Press Response
Following the collapse, the press was quickly asked to leave the room. The event resumed about 30 minutes later, at which point President Trump provided an update on Findlay's condition.
President Trump gave an update on the executive's health when the press conference resumed.
Summary
The sudden collapse of a drug executive during a high-profile press conference highlighted the unexpected nature of live events but did not overshadow the announcement aimed at lowering drug prices.
Would you like the summary to be more formal or casual?